These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38215269)

  • 1. A Smartphone App for Real-Time Assessment of Malaria Prophylaxis Adverse Events.
    Rodriguez-Valero N; Ledesma-Carbayo MJ; Martí-Soler H; Cuadrado Sanchez D; Vladimirov A; Camprubí-Ferrer D; Pinazo MJ; Losada I; Almuedo-Riera A; Romero L; Roman A; Vera I; Roldan-Torralvo M; Ferrer E; de Alba T; Jimenez A; Gómez-Valverde JJ; Muñoz J; Luengo Oroz M
    Telemed J E Health; 2024 May; 30(5):1436-1442. PubMed ID: 38215269
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
    DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA
    J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
    Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®).
    Rodriguez-Valero N; Carbayo ML; Camprubí-Ferrer D; Martí-Soler H; Sanchez DC; Vladimirov A; Pinazo MJ; Almuedo-Riera A; Roman A; Vera I; Roldan M; de Alba T; Jimenez A; Gómez-Valverde JJ; Oroz ML; Muñoz J
    Travel Med Infect Dis; 2022; 49():102356. PubMed ID: 35589007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
    Lopez-Velez R; Bayas JM
    J Travel Med; 2007; 14(5):297-305. PubMed ID: 17883460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E
    J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria Surveillance - United States, 2017.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to malaria prophylaxis among travelers from a middle-income country.
    Rodrigues KMP; Costa ABFD; Santoro-Lopes G
    Rev Soc Bras Med Trop; 2019 Jun; 52():e20190014. PubMed ID: 31188918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study.
    Ferrara P; Masuet-Aumatell C; Agüero F; Ramon-Torrell JM
    Malar J; 2018 Apr; 17(1):134. PubMed ID: 29606127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to malaria prophylaxis among Peace Corps Volunteers in the Africa region, 2013.
    Landman KZ; Tan KR; Arguin PM
    Travel Med Infect Dis; 2015; 13(1):61-8. PubMed ID: 25534297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
    Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
    Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.